Erbez Georgia
- SEC CIK
- 0001557930
In the past year, 2 open-market sale filings worth $20.7K and no purchases.
Current role at each company
- CDXS Codexis, Inc.See Remarksas of Feb 25, 2026
- CHRS Coherus Oncology, Inc.Directoras of Jun 13, 2025
- SRRA Sierra Oncology, Inc.Directoras of Jul 1, 2022
- HARP Harpoon Therapeutics, Inc.Chief Financial Officeras of Feb 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $20.7K
- 2 filings
- Net
- −$20.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Erbez Georgia as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CDXS Codexis, Inc.
See Remarks2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 (view filing) | Feb 6 | 3 days | Erbez GeorgiaSee Remarks | SSale | −3.83K | $1.31 | −$5.01K | −5.4%66.8K after | |
| Oct 15, 2025 (view filing) | Oct 13 | 2 days | Erbez GeorgiaChief Financial Officer | SSale | −6.24K | $2.51 | −$15.7K | −8.1%70.6K after |
HARP Harpoon Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2021 (view filing) | Sep 22 | Same day | Erbez GeorgiaChief Financial Officer | PPurchase | +10.3K | $8.10 | +$83.4K | +115.5%19.2K after |